Greg Deda Breaks Through as London Bidding Tightens Supply

Economic Insider Staff on May 22, 2026

The room did a small double-take when Greg Deda’s Abstract Awakening II cleared £50,000 at Tate Ward’s Urban & Contemporary Art sale in September 2025. The mixed media canvas, measuring roughly 152.5 by 122 centimeters, had been estimated at £40,000 to £60,000; it landed in that band yet carried a charge that numbers alone rarely explain.

The work finished ahead of several lots by better-known names, including prints by Banksy and Keith Haring, a detail that caught the attention of advisors who make their living reading the mood of the room. The bidding did not feel tentative; it felt like collectors had already made up their minds about where Deda should sit in the pecking order, and they were racing to catch up with that conviction.

For many observers, the final hammer price read less like a surprise and more like confirmation that something had quietly been building around the Toronto-based painter. Auction houses host records every week, yet this lot carried a different energy: here was an artist still early in his secondary market journey, suddenly commanding a figure that forces galleries, collectors, and advisors to recalibrate in real time.

A London advisor who watched the sale summed it up bluntly afterward: “Once a painting crosses that line in a public sale, it stops being a curiosity and becomes a subject of serious attention,” the advisor said. “People stop asking whether the work deserves its place and start wondering how they can be part of the conversation.”

From Quiet Following to Wider Recognition

Greg Deda had already been gathering a loyal base of admirers through exhibitions in London, New York, and Toronto, where his blend of abstraction and magic realism lent his canvases a layered, dream-soaked intensity. He studied at the Scuola Dei Beni Culturali in Italy and later at Kunst Schule in Germany, absorbing Renaissance frescoes and post–Berlin Wall experimentation before folding those lessons into a contemporary language of texture, myth, and memory.

By the time Abstract Awakening II reached the auction block, his paintings had already filtered into private collections across Europe and North America. The Tate Ward result brought his name to a broader audience, advisors, curators, and critics who had followed the secondary market closely but had not yet focused their full attention on his work.

In the weeks that followed, advisory firms in London and major European hubs reported a sharp rise in enquiries about his practice, his exhibition history, and where his work could be seen. That kind of attention, arriving quickly, spanning continents, is the marker not of a passing trend but of an artist whose moment of wider recognition has arrived.

Inside Deda’s Imagined Realities

Greg Deda’s paintings do not yield themselves at a glance. Surfaces build slowly, with layers of paint and mixed media forming an intricate skin of texture, movement, and symbol. His practice moves between abstraction and magic realism, where figures and fragments of narrative flicker through stormy fields of colour.

Critics who followed his recent exhibition Vision & Value at Chelsea Fine Art Gallery in London described the canvases as “dreamlike” and “ambiguous,” with scenes that feel half-remembered, half-foretold. Deda himself has said that his work springs from a dialogue between conscious thought and the submerged currents of dreaming. “My work is a mélange of both the conscious and the subconscious,” he told one interviewer. “Our dreams carry hidden emotions and truths, and painting becomes the place where I try to pull those fragments into daylight.”

That sensibility runs straight through Abstract Awakening II. The composition surges with gestural marks and abrupt shifts in tone, then slows into passages where forms almost crystallize into figures, only to dissolve again. It reads like a threshold painting: confident, resolved, and unmistakably the work of someone who has lived inside both classical workshops and contemporary studios.

The piece has already been described by dealers as a defining canvas, a work that encapsulates his move into a higher tier of recognition. Chelsea Gallery lists it as sold, while Aurum Fox presents it as a landmark in his career, symbolizing both artistic maturity and the sharp rise in global attention. Those descriptions might sound grand if the critical response were quiet; after September 2025, they simply match the evidence.

A Career at Full Stride

Auction results are rarely just numbers. When a work by a mid-career artist finds genuine competition in a public sale, not from passing curiosity but from collectors who have studied the work and decided they want to live with it, something shifts in how that artist is understood. The September 2025 result did exactly that for Deda: it moved him from a name spoken quietly among a circle of early admirers into one discussed across rooms he had not yet entered.

Advisors across London, Paris, and Berlin now count Deda among the artists whose exhibitions and auction appearances draw consistent attention from collectors and curators alike. The interest is no longer confined to a local following; it spans institutions and individuals in the United Kingdom, continental Europe, and North America, many of whom now track his exhibition schedule alongside the broader conversation about where contemporary painting is headed.

Art history offers plenty of examples in which a decisive public result marked the moment an artist moved from critically admired to broadly recognized. That transition rarely announces itself in advance. It tends to arrive, as it did for Deda in September 2025, through a single room full of people who have quietly made up their minds.

Greg Deda sounds fully aware of that reality yet remains focused on the studio rather than the saleroom. He continues to work between Toronto and New York, building cycles of paintings that move between mythic scenes and charged abstractions. The September auction did not change his habits, but it did confirm what those closest to his work had long believed: that the paintings were ready for a larger conversation, and the larger conversation was now ready for them.

ADNOC Says Full Hormuz Shipping May Not Return Until 2027

Economic Insider Staff 2 on May 22, 2026

Strait of Hormuz shipping routes remained under pressure this week after UAE energy company ADNOC said normal tanker movement through the region may not fully recover until the first half of 2027. The outlook added fresh uncertainty to global energy markets already facing elevated freight costs and longer shipping times.

ADNOC, one of the Middle East’s largest state-owned energy producers, said the prolonged disruptions could continue affecting crude transportation through one of the world’s most important oil transit corridors. The Strait of Hormuz connects Gulf exporters with major customers across Asia, Europe, and North America.

Shipping operators, insurers, refiners, and commodity traders have continued monitoring traffic conditions as companies adjust routes and reassess logistical risks. While some Gulf states maintain alternative export infrastructure, the strait remains a critical route for crude shipments from Saudi Arabia, the United Arab Emirates, Kuwait, Iraq, and Qatar.

ADNOC Signals Extended Timeline for Shipping Recovery

ADNOC’s latest outlook indicated that logistical disruptions affecting tanker operations could continue for several more quarters, extending beyond earlier market expectations. Reduced shipping capacity and operational delays have already pushed freight costs higher across energy transportation markets this year.

Global oil markets reacted to the development as traders assessed the possibility of prolonged export constraints. Brent crude futures remained elevated during Thursday trading, while energy-related equities and commodity markets continued experiencing volatility.

The Strait of Hormuz remains one of the world’s busiest oil transit routes, handling millions of barrels of crude and petroleum products each day. Even limited disruptions can affect refinery schedules, inventory management, and import planning for major energy-consuming economies.

Several tanker operators have reduced transit frequency or adopted stricter routing procedures in recent months, contributing to longer delivery times and higher shipping expenses. Industry specialists said prolonged maritime disruptions can also increase insurance costs, storage expenses, and broader supply-chain pressures for fuel-importing countries.

Global Energy Markets Adjust to Higher Transportation Costs

The shipping outlook has become increasingly important for global energy markets as oil demand remains stable across major economies. Asian importers continue accounting for a large share of Gulf crude purchases, making reliable transport routes critical for procurement planning.

Refineries in China, India, Japan, and South Korea remain among the largest buyers of Middle Eastern crude exports. Prolonged limitations on shipping capacity through the Strait of Hormuz could force importers to seek alternative supply arrangements or expand strategic fuel reserves.

Commodity shipping rates have reflected ongoing uncertainty in regional maritime conditions. Tanker charter costs increased in recent weeks as vessel operators adjusted pricing to account for higher operational and logistical risks.

Energy economists said transportation bottlenecks can affect crude availability even when oil production levels remain stable. The developments have also renewed attention on strategic petroleum reserves maintained by countries including the United States, China, and Japan to help manage potential supply disruptions.

Shipping Operators and Insurers Reassess Regional Exposure

Maritime insurance markets have experienced notable changes as underwriters evaluate risk conditions affecting commercial vessels operating near major energy export routes. Higher insurance premiums for tankers transiting the Gulf region have added further costs to crude transportation.

Shipping companies have increasingly incorporated contingency planning into operational schedules, including route diversification, revised crew procedures, and expanded coordination with port authorities. Some operators have reportedly adjusted fleet deployment strategies to reduce exposure to congested transit periods.

Port infrastructure throughout the Gulf region remains operational, though shipping efficiency has varied depending on vessel traffic patterns and logistical conditions. Export terminals in the United Arab Emirates and neighboring producers continue processing crude shipments despite transportation constraints.

The UAE has invested heavily in energy infrastructure designed to support export resilience, including pipeline networks and storage facilities connected to ports outside the Strait of Hormuz. These projects were developed partly to improve logistical flexibility during periods of maritime disruption.

Saudi Arabia has similarly expanded pipeline capacity connecting oil production areas to Red Sea export terminals. However, industry experts note that alternative routes cannot entirely replace the shipping volumes traditionally handled through the Strait of Hormuz.

Oil Producers and Importers Monitor Long-Term Supply Stability

The extended timeline outlined by ADNOC comes at a time when global energy demand forecasts remain relatively firm despite uneven economic growth across several regions. Industrial activity, aviation fuel consumption, and petrochemical manufacturing continue supporting oil demand in key markets.

Large commodity trading firms have reportedly increased monitoring of inventory positions and storage capacity in response to ongoing transportation uncertainty. Some traders have sought additional supply contracts outside the Gulf region to diversify sourcing options.

The Organization of the Petroleum Exporting Countries and allied producers remain influential in balancing global oil supply conditions. Export logistics, however, have become increasingly significant alongside production policy decisions in determining how efficiently crude reaches international buyers.

Financial markets have also reacted to broader inflation implications associated with higher transportation costs. Elevated energy prices can affect manufacturing expenses, freight pricing, and consumer fuel costs across multiple sectors of the global economy.

Airlines, shipping companies, chemical manufacturers, and industrial producers are among the industries most sensitive to sustained increases in fuel-related expenses. Equity analysts have monitored these sectors closely as commodity prices and freight rates fluctuate.

The Professional Path of Anil K. Sharma and the Expansion of Outpatient Interventional Pain Medicine

Economic Insider Staff on May 22, 2026

Back pain became big business in American healthcare long before most hospital systems fully understood how large the demand would become. By the late 1990s, pain clinics had started appearing across suburban medical corridors, especially in states with growing outpatient networks. Some focused on rehabilitation. Others leaned heavily into spinal injections and minimally invasive procedures. Insurance companies were changing policies. Hospitals were moving procedures outside inpatient operating rooms. At the same time, millions of Americans were dealing with chronic pain tied to disc disease, arthritis, spinal stenosis, and nerve damage. The field was expanding quickly, though standards were still uneven from one practice to another.

That was the environment Anil K. Sharma entered after finishing years of medical training in both India and the United States. Sharma graduated from Mahatma Gandhi Memorial Medical College in Indore as valedictorian before relocating to America for postgraduate medical training. He completed an internal medicine internship at Nassau County Medical Center in New York between 1990 and 1991. From there, he joined the anesthesiology residency program at Monmouth Medical Center in New Jersey. Colleagues there later selected him as chief resident. He also received the Robert D. Dripps Award, which is given to the residency program’s top graduating physician.

Pain medicine itself was changing during those years. Physicians who originally trained in anesthesiology were beginning to specialize in image-guided spinal procedures. Fluoroscopy became more common. Outpatient treatment centers expanded. Surgical referrals increased. Sharma continued into fellowship training at the Cleveland Clinic Foundation from 1994 through 1995, focusing specifically on pain management. He graduated as the fellowship program’s top fellow. The timing mattered because the specialty was becoming more organized academically and clinically. National organizations were beginning to develop procedural standards, training recommendations, and evidence-based guidelines that would later define the specialty.

In 1996, Sharma founded Spine & Pain Centers of New Jersey & New York. The practice started at a point when outpatient interventional pain care was becoming more common across the country. Rather than relying entirely on hospital-based treatment, many physicians were building office-centered practices that combined consultations, imaging review, follow-up care, and minimally invasive procedures. Sharma’s work focused largely on spinal conditions, including radiculopathy, herniated discs, chronic neck pain, lower back pain, and neuropathic disorders. Procedures included epidural steroid injections, medial branch blocks, facet interventions, and radiofrequency denervation.

The practice later expanded across several New Jersey locations, including Freehold, Millburn, Shrewsbury, Neptune, and Toms River. Sharma also became involved with ambulatory surgical centers connected to those regions. Patients increasingly preferred outpatient settings because procedures could often be completed in a few hours instead of requiring overnight hospitalization. According to federal healthcare estimates, outpatient surgical visits in the United States increased sharply during the early 2000s, particularly in orthopedic and spinal specialties. Sharma’s procedural volume grew alongside those trends. Over the course of more than two decades, he performed tens of thousands of spinal interventional procedures.

His hospital work continued at the same time. In 2003, Sharma became Director of Pain Management at Monmouth Medical Center in Long Branch, New Jersey. The role placed him inside a larger hospital system while he continued outpatient practice development. Pain management programs during that period were becoming increasingly multidisciplinary. A single patient might move between orthopedic surgery, physical therapy, neurology, rehabilitation medicine, and interventional treatment over the course of care. Hospital pain directors often had responsibilities that extended beyond procedures themselves, including physician coordination, protocol review, and committee participation.

In addition to his professional experience in the field, Sharma has worked for many years with national organizations related to the spine and interventional pain management. For example, from 2007 to 2020, he was a member of the Standards Committee of the Spine Intervention Society. He was even the vice chairman of the Standards Committee during 2012-2013 and co-chaired the society’s annual meeting. Organizations such as the Spine Intervention Society gained increasing importance due to pressure from insurance companies and health care systems to establish procedural guidelines and standards for pain management.

Sharma also became active within the North American Spine Society. Beginning in 2007, he served on the organization’s Evidence-Based Clinical Guidelines Committee. He later joined the editorial board of SpineLine, the society’s publication focused on spinal treatment developments and clinical discussion. During those years, evidence-based medicine became central to healthcare policy conversations. Physicians and medical societies were under pressure to justify treatment recommendations through published research and guideline development. Sharma participated in projects connected to cervical radiculopathy, lumbar disc herniation, low back pain, and adult isthmic spondylolisthesis.

His academic writing reflected many of the same themes found in his clinical work. In 2016, Sharma authored and co-authored systematic reviews published in Pain Medicine Journal examining lumbar interlaminar epidural steroid injections. The reviews evaluated available clinical evidence surrounding image-guided and non-image-guided techniques. He also contributed articles to SpineLine discussing anticoagulants and spinal injections as well as radiofrequency denervation procedures. Beyond journals, Sharma wrote textbook chapters for Interventional Pain Management: A Practical Approach and Symptom-Oriented Pain Management, focusing on discogenic pain and spinal intervention techniques.

Recognition followed throughout much of his career, though often through regional and professional publications rather than national media attention. During the years from 2013 through 2024, Dr. Sharma has been featured several times in New Jersey Monthly’s list of “Top Doctors” in pain management. He was also mentioned in materials published by professional medical societies, as well as other institutions, in connection with outpatient care in spinal pain management in New Jersey.

Dr. Anil K. Sharma still works in the same field, which has seen considerable development since he started working. The field of interventional pain medicine has changed substantially since Dr. Sharma graduated from his pain management fellowship in the middle of the 1990s. Sharma’s career unfolded alongside many of those developments, linking clinical practice, procedural medicine, physician education, and long-term involvement in organized pain management

Disclaimer: This article is intended for informational and editorial purposes only. It does not provide medical advice, diagnosis, or treatment recommendations. Readers should consult a qualified healthcare professional before making decisions related to pain management, spinal procedures, or any medical condition.